Identification and management of mental health issues by dermatologic surgeons: a survey of American Society for Dermatologic Surgery members

Dermatologists have long been interested in mental health issues of their patients. Some psychosocial distress likely motivates the pursuit of cosmetic dermatologic treatments. However, a percentage of patients seeking treatment suffer from significant psychopathology, such as body dysmorphic disord...

Full description

Saved in:
Bibliographic Details
Published inDermatologic surgery Vol. 41; no. 3; p. 352
Main Authors Sarwer, David B, Spitzer, Jacqueline C, Sobanko, Joseph F, Beer, Kenneth R
Format Journal Article
LanguageEnglish
Published United States 01.03.2015
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Dermatologists have long been interested in mental health issues of their patients. Some psychosocial distress likely motivates the pursuit of cosmetic dermatologic treatments. However, a percentage of patients seeking treatment suffer from significant psychopathology, such as body dysmorphic disorder (BDD), which may contraindicate treatment. To assess dermatologic surgeons' strategies for identification and management of mental health issues among patients seeking cosmetic procedures. A survey was sent to 2,855 practicing members of the American Society for Dermatologic Surgery by e-mail. Two hundred sixty members completed the survey (9.1%). Approximately, 60% of respondents indicated that they ask new patients about psychiatric treatment history, and 92% reported that they have declined to provide a cosmetic treatment because of concerns about mental health status. Most (94%) indicated that they were aware of BDD, and 62% indicated that they refused to treat a patient believed to have BDD. Respondents estimated that 13% of new patients had BDD and 63% considered BDD to be a contraindication to treatment. Approximately 60% of dermatologic surgeons inquire about the mental health issues of their cosmetic patients. Most are aware of BDD, but less than two-thirds consider it a contraindication to treatment.
ISSN:1524-4725
DOI:10.1097/DSS.0000000000000279